CoreWeave (CRWV) Form 144: Proposed Sale of 63,230 Shares ($7.29M)
CoreWeave, Inc. (CRWV) filing a Form 144 notifies a proposed insider sale of 63,230 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $7,289,772.07 and an approximate sale date of 09/11/2025 on NASDAQ.
Rhea-AI Filing Summary
CoreWeave, Inc. (CRWV) filing a Form 144 notifies a proposed insider sale of 63,230 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $7,289,772.07 and an approximate sale date of 09/11/2025 on NASDAQ. The shares were acquired as restricted stock units (compensation) and dated 09/11/2025 with payment listed as compensation. The filing also records a prior sale by Nitin Agrawal of 6,010 shares on 08/20/2025 for $540,858.66. The signer represents no undisclosed material adverse information.
Positive
- None.
Negative
- Proposed sale of 63,230 Class A shares valued at $7,289,772.07 scheduled for 09/11/2025 via Morgan Stanley Smith Barney
- Insider disposition activity includes a prior sale of 6,010 shares on 08/20/2025 for $540,858.66
Insights
TL;DR: Insider plans to sell ~63k shares (RSUs) worth $7.29M; prior small sale recorded.
The notice documents a proposed Rule 144 sale of 63,230 Class A shares acquired as restricted stock units and scheduled for 09/11/2025 via Morgan Stanley Smith Barney. The filing is procedural, meeting disclosure requirements for resale of recently vested compensation shares. The prior sale of 6,010 shares on 08/20/2025 for $540,858.66 is disclosed, showing recent insider disposition activity. From a capital-markets perspective, this is a material-sized single transaction in absolute dollars but the filing provides no information on insider intent, company performance, or lock-up constraints.
TL;DR: Rule 144 notice documents compliance for sale of compensation shares; disclosure aligns with securities rules.
The Form 144 presents the mechanics of a proposed sale: acquisition date, nature (RSUs/compensation), broker, and aggregate market value. The signer explicitly represents that they lack undisclosed material adverse information, a standard attestation. The document lacks additional governance context such as a 10b5-1 plan adoption date or beneficial ownership details, so governance implications are limited to routine compliance disclosure.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does CoreWeave (CRWV) Form 144 filed here disclose?
Who is the broker handling the proposed sale in the filing?
Does the filing state any undisclosed material information about CoreWeave operations?
What prior insider sale is reported in this Form 144?
Is there any information about a 10b5-1 trading plan in the filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.